ST14 抗体 (AA 566-855)
Quick Overview for ST14 抗体 (AA 566-855) (ABIN7171018)
抗原
See all ST14 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 566-855
-
交叉反应
- 人
-
纯化方法
- Antigen Affinity purified
-
免疫原
- Recombinant Human Suppressor of tumorigenicity 14 protein (566-855AA)
-
亚型
- IgG
-
-
anti-Suppression of Tumorigenicity 14 (ST14) (AA 11-100) antibody
ST14 适用: 人 WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (AA 607-852) antibodyST14 适用: 人 WB, IHC 宿主: 小鼠 Monoclonal C4 unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (Internal Region) antibodyST14 适用: 人, 小鼠 WB, IHC, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) antibodyST14 适用: 人, 小鼠, 大鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (C-Term) antibodyST14 适用: 人, 小鼠, 大鼠, Cow, 豚鼠, 马, 犬, Pig, 兔 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (N-Term) antibodyST14 适用: 人 WB, IF, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) antibodyST14 适用: 人, 小鼠 IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (AA 298-400) antibodyST14 适用: 人 ELISA 宿主: 小鼠 Monoclonal 2F4 unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (AA 10-59) antibodyST14 适用: 人 WB, IHC, ELISA, IF, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (AA 826-855), (C-Term) antibodyST14 适用: 人, 小鼠 WB, IHC (p) 宿主: 兔 Polyclonal RB2080 unconjugated
-
-
应用备注
- Recommended dilution: IHC:1:20-1:200,
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ST14 (Suppression of Tumorigenicity 14 (ST14))
-
别名
- ST14
-
背景
-
Background: Degrades extracellular matrix. Proposed to play a role in breast cancer invasion and metastasis. Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site. Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing.
Aliases: Epithin antibody, HAI antibody, Matriptase antibody, Membrane type serine protease 1 antibody, Membrane type serine protease antibody, Membrane-type serine protease 1 antibody, MT SP1 antibody, MT-SP1 antibody, MTSP 1 antibody, MTSP1 antibody, Prostamin antibody, PRSS 14 antibody, PRSS14 antibody, Serine protease 14 antibody, Serine protease TADG 15 antibody, Serine protease TADG-15 antibody, Serine protease TADG15 antibody, SNC 19 antibody, SNC19 antibody, ST 14 antibody, ST14 antibody, ST14_HUMAN antibody, Suppression of tumorigenicity 14 (colon carcinoma matriptase epithin) antibody, Suppression of tumorigenicity 14 (colon carcinoma) antibody, Suppression of tumorigenicity 14 antibody, Suppressor of tumorigenicity 14 protein antibody, Suppressor of tumorigenicity protein 14 antibody, TADG 15 antibody, TADG15 antibody, TMPRSS14 antibody, Tumor associated differentially expressed gene 15 protein antibody, Tumor-associated differentially-expressed gene 15 protein antibody
-
UniProt
- Q9Y5Y6
抗原
-
